US Broker Ratings

Olema Pharmaceuticals, Inc. (OLMA): Analyst Ratings Suggest a 41.1% Upside for This Biotech Innovator

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is a promising player in the biotechnology sector, focusing on groundbreaking therapies for women’s cancers. As a clinical-stage biopharmaceutical company, Olema is at the forefront..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a Potential 444% Upside in the Biotech Arena

For investors with a keen eye on the biotechnology sector, Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) presents an intriguing opportunity marked by both promise and risk. With its focus on..

Neuronetics, Inc. (STIM) Stock Analysis: A 322% Upside Potential Amid Rapid Revenue Growth

Neuronetics, Inc. (NASDAQ: STIM) is catching the attention of savvy investors thanks to its remarkable potential upside of over 322% and a robust revenue growth rate of 101.30%. As a..

Erasca, Inc. (ERAS) Stock Analysis: A Biotech with a 40.80% Potential Upside and Promising Oncology Pipeline

Erasca, Inc. (NASDAQ: ERAS), a clinical-stage biotechnology company, is making waves in the healthcare sector with its focus on precision oncology. With a market cap of $1.03 billion, Erasca is..

Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Healthcare Innovator Poised for 71.52% Upside

Alpha Tau Medical Ltd. (NASDAQ: DRTS), an Israeli biotechnology company specializing in innovative cancer therapies, is capturing the attention of investors with a standout potential upside of 71.52%. Operating in..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: A 47% Potential Upside Beckons Biotech Investors

Entrada Therapeutics, Inc. (NASDAQ: TRDA) is capturing the attention of investors with its promising potential upside of 47.06%, driven by innovative biotechnology developments and strong analyst confidence. As a clinical-stage..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Biotechnology Innovator with a 154% Potential Upside

Compass Therapeutics, Inc. (NASDAQ: CMPX) is capturing the attention of investors within the healthcare sector, specifically in the biotechnology industry. Headquartered in Boston, Massachusetts, this clinical-stage company is at the..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A Biotech Powerhouse with 18% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is capturing the attention of investors with its promising pipeline in the biotechnology sector. As a company dedicated to developing innovative therapies for hematologic disorders..

Chevron Corporation (CVX) Stock Analysis: A 15.26% Potential Upside Amidst Energy Sector Volatility

Chevron Corporation (NYSE: CVX), a titan in the integrated oil and gas industry, stands as a stalwart in the energy sector with a substantial market capitalization of $301.26 billion. Based..

National Research Corporation (NRC) Stock Analysis: A Deep Dive into Its High Return on Equity and Dividend Yield

National Research Corporation (NRC), a key player in the Health Information Services industry, has carved a niche by providing analytics and insights to improve patient and employee experiences across healthcare..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Unlocking a 170% Upside Potential in the Healthcare Sector

Nano-X Imaging Ltd (NNOX), an innovative player in the healthcare sector, is making waves in the field of medical imaging with its cutting-edge digital X-ray technology. Headquartered in Petah Tikva,..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Biotech Pioneer with a 325% Upside Potential

Abeona Therapeutics Inc. (NASDAQ: ABEO) is currently capturing significant attention from investors, partly due to its compelling upside potential of over 325%. As a trailblazing entity in the biotechnology sector,..

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a 91.49% Potential Upside in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO) is carving a niche in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. As a U.S.-based company with a market capitalization..

Varex Imaging Corporation (VREX) Stock Analysis: A 44% Upside Potential Amid Medical Device Market Growth

Investors eyeing opportunities in the healthcare sector should take a closer look at Varex Imaging Corporation (NASDAQ: VREX), a key player in the medical devices industry with a notable potential..

Mereo BioPharma Group plc (MREO) Stock Analysis: Exploring a Potential 273.63% Upside in the Biotech Sector

Mereo BioPharma Group plc (NASDAQ: MREO), a distinguished name in the biotechnology sector, has emerged as a compelling player for investors keen on the healthcare space. With a current market..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unlocking Growth Potential with a 19.54% Upside

Cytek Biosciences, Inc. (NASDAQ: CTKB), a prominent player in the medical devices sector, has been making waves with its innovative cell analysis solutions. With a market capitalization of approximately $615.03..

Spok Holdings, Inc. (SPOK) Stock Analysis: Evaluating a 56% Upside Amidst High Dividend Yield

Investors seeking robust dividend income and potential price appreciation should take a closer look at Spok Holdings, Inc. (NYSE: SPOK). With a market capitalization of $276.63 million, Spok operates in..

Outset Medical, Inc. (OM) Stock Analysis: Exploring a 251% Potential Upside in the Innovative Hemodialysis Market

Investors with an eye on the healthcare sector might find Outset Medical, Inc. (NASDAQ: OM) an intriguing prospect, particularly given its potential upside of 251.46%. This figure is driven by..

10x Genomics, Inc. (TXG) Stock Analysis: Exploring the 8.77% Potential Upside in Health Information Services

Investors with an eye on the healthcare sector might find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing prospect. Headquartered in Pleasanton, California, this life science technology company specializes in creating..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating a Challenging Landscape with Resilient Fundamentals

Pediatrix Medical Group, Inc. (NYSE: MD), a prominent player in the healthcare sector, specifically within the medical care facilities industry, has been drawing investor attention with its specialized focus on..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds